RSV

2023 - 12 - 28

Post cover
Image courtesy of "The Guardian"

Vaccine could cut RSV hospital admissions in babies by 80%, study ... (The Guardian)

International research indicates giving infants nirsevimab would cause sharp drop in rates of respiratory syncytial virus infection.

Post cover
Image courtesy of "Sky News"

RSV vaccine could cut baby hospital admissions by more than 80 ... (Sky News)

Respiratory syncytial virus (RSV) is a very common virus and most children will go through it without complications by the time they are two.

Post cover
Image courtesy of "MedPage Today"

Nirsevimab Reduced Hospitalizations for Infants With RSV (MedPage Today)

"We now have a way of preventing 80% of [infant] admissions due to RSV," Faust told MedPage Today. Very severe RSV-associated lower respiratory tract infection ...

expert reaction to study looking at nirsevimab preventive antibody ... (Science Media Centre)

A study published in the New England Journal of Medicine looks at nirsevimab for the prevention of RSV hospitalisations in infants.

Post cover
Image courtesy of "Braintree and Witham Times"

Winter virus jab for babies 'can cut RSV-related hospital admissions ... (Braintree and Witham Times)

The treatment could help ease seasonal pressures on the NHS, researchers said.

Post cover
Image courtesy of "nejm.org"

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants ... (nejm.org)

Abstract Background The safety of the monoclonal antibody nirsevimab and the effect of nirsevimab on hospitalizations for respiratory syncytial virus ...

Economic Burden of RSV Among High-Risk US Adults Is Substantial (Infectious Disease Advisor)

The economic burden of respiratory syncytial virus (RSV) among high-risk adults is substantial, suggesting the need to identify preventive interventions to ...

Post cover
Image courtesy of "The BMJ"

RSV jab reduced infant hospital admissions by 83%, study reports (The BMJ)

The study also found that very severe RSV associated lower respiratory tract infections occurred in five infants who received nirsevimab and 19 infants who ...

Post cover
Image courtesy of "Evening Standard"

What is RSV and why do babies get it so badly? (Evening Standard)

A winter vaccine for babies could cut down hospital admissions for Respiratory Syncytial Virus (RSV) by 80%, a new study has revealed.

Post cover
Image courtesy of "CIDRAP"

Nirsevimab effective in preventing RSV hospitalizations in phase 3 trial (CIDRAP)

Beyfortus (nirsevimab), a monoclonal antibody approved this summer for use in infants to protect against respiratory syncytial virus (RSV), is effective in ...

Post cover
Image courtesy of "HealthDay"

Nirsevimab Protects Infants Against RSV-Linked Hospitalization (HealthDay)

Nirsevimab efficacious for preventing RSV-associated lower respiratory tract infection and very severe RSV-associated LRTI. Nirsevimab Protects Infants ...

Post cover
Image courtesy of "Salt Lake Tribune"

Utah's flu activity is 'rapidly' increasing, data shows, as COVID-19 ... (Salt Lake Tribune)

Flu, COVID-19 and RSV activity are increasing in Utah, and health officials expect hospitalizations and infections to keep rising through the winter.

Explore the last week